Search results (36)
« Back to News & OpinionNews and Opinion from the Pandemic Sciences Institute at the University of Oxford
University of Oxford unveils new vaccine development partnership
15 November 2024
Partner news Research news Vaccines, treatments, diagnostics & trials
Oxford Cancer, the Oxford Vaccine Group and the Pandemic Sciences Institute have announced a new collaboration with Belgian biotech innovator Univercells.
New study traces impact of COVID-19 pandemic on global movement and evolution of seasonal flu
11 November 2024
Epidemiology & data Pathogen biology & new threats Research news
Increased genomic surveillance capacity allowed a deeper insight into the global distribution patterns of seasonal flu and other respiratory viruses.
Reconstructing a lifetime of flu infections to understand long-term trends
8 November 2024
Epidemiology & data Research news
Using antibody data and mathematical modelling, a new study estimates annual patterns of influenza infection and protection over the past fifty years.
Large-scale study on Long Covid highlights urgent, global need for investment
22 October 2024
Epidemiology & data Research news
A new study in BMJ Global Health reveals the key Long Covid characteristics affecting populations worldwide, including fatigue, shortness of breath and having trouble thinking clearly. 6-12 months after hospital discharge, 70% of study participants were affected by Long Covid in high-income countries, and 42% in low and middle-income countries.
Study suggests possible new transmission route for highly pathogenic avian influenza
17 October 2024
Epidemiology & data Pathogen biology & new threats Research news
Understanding actual “bird flu” rates in humans will help prevent further spillover and a potential new pandemic.
Study explores aerosol immunisation as path to broadly protective influenza vaccine
16 October 2024
Research news Vaccines, treatments, diagnostics & trials
Scientists at PSI and Pirbright have taken a significant step towards developing a universal influenza vaccine.
Professor Sassy Molyneux awarded NIHR Global Health Research Professorship
5 September 2024
PSI Investigator Professor Sassy Molyneux has received a prestigious five-year NIHR Global Health Research Professorship. This award, granted to only five distinguished scientists annually, will support Professor Molyneux’s research on protecting frontline staff from moral distress.
COVID-19 phone app shown to provide real-time information on the spread of infectious diseases
12 July 2024
Epidemiology & data Research news
Researchers analysing data from mobile phone apps used during the COVID-19 pandemic found that digital contact tracing can help public health bodies to better monitor and analyse evolving epidemics.
Pandemic computer simulations to guide future vaccine trials
23 May 2024
Epidemiology & data Research news Vaccines, treatments, diagnostics & trials
PSI scientists are launching a new computer simulations project to model vaccine clinical trial designs and strengthen global response to pandemic threats.
New ethical framework for coercive antimicrobial stewardship policies
29 April 2024
Ethics, social science & humanities Research news
Published in the journal Public Health Ethics, the research introduces an ethical framework for assessing the use of coercive antimicrobial stewardship policies to address the ‘silent pandemic’ of antimicrobial resistance.
Researchers enrol record number of patients for landmark plague trial
26 April 2024
Research news Vaccines, treatments, diagnostics & trials
A randomised controlled trial to evaluate the efficacy and safety of treatments for bubonic plague has enrolled over 220 patients in Madagascar, marking a critical milestone in evidence generation for plague treatments.
New Pandemic PACT research programme launched
21 March 2024
Ethics, social science & humanities Research news
The Pandemic Sciences Institute, in collaboration with the global coalition of health research funders GloPID-R and UKCDR, has launched a new research programme including an interactive platform to track and analyse over $7 billion in global pandemic research funding.
Study reveals high number of persistent COVID-19 infections in the general population
21 February 2024
Epidemiology & data Research news
A new study – led by researchers at PSI – has found that a high proportion of SARS-CoV-2 infections in the general population lead to persistent infections lasting a month or more. The findings have been published today in the journal Nature.
Vaccine trial for deadly Nipah virus launched
11 January 2024
Nipah virus Research news Vaccines, treatments, diagnostics & trials
Oxford-led UK trial is first step to developing a vaccine against Nipah virus – a devastating disease mostly found in South-East Asia.
Study reveals that duration of exposure to COVID-19 plays major role in risk of catching the virus
20 December 2023
Epidemiology & data Research news
Using data from 7 million people notified by the NHS COVID-19 contact tracing app, this is the first large-scale study to reveal how duration and proximity of contact with an infected person affects how COVID-19 is spread.
Nipah virus: How a neglected disease raises new ethical questions
18 December 2023
Ethics, social science & humanities Nipah virus Research news
New University of Oxford research brings to light important ethical considerations in Nipah virus outbreak control, its treatment, and research into vaccines.
Funders Roadmap is supporting better clinical trials
14 December 2023
Ethics, social science & humanities Research news
New framework helps funders to support coordinated, effective and equitable clinical trials in response to epidemics and pandemics.
Call for applications to establish networks of epidemic and pandemic sciences research excellence across Africa
16 November 2023
PSI has joined forces with the Science for Africa Foundation and the Mastercard Foundation to launch a call for applications to establish innovative networks of research excellence in epidemic and pandemic sciences across Africa.
CEPI and University of Oxford advance vaccine work against potentially deadly Arenaviruses
2 November 2023
Research news Vaccines, treatments, diagnostics & trials
CEPI will provide up to $25 million to the University of Oxford to complete early development of prototype vaccines against the Junín virus, with a new project led by Professor Teresa Lambe.
World-leading RECOVERY trial expands to investigate treatments for influenza
30 October 2023
Research news Vaccines, treatments, diagnostics & trials
The RECOVERY trial, the leading global clinical trial of treatments for COVID-19, has expanded to find effective treatments for patients hospitalised with flu.